© 2022 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Two experimental vaccine approaches, using mRNA protein delivery and germline targeting, are in the early stages of development.
A single dose of the HIV capsid inhibitor reduced viral load in highly treatment-experienced people.
Early studies of dapivirine lubricant for anal sex indicate how far the field has come—and how far it still has to go.
To date, no head-to-head trial has compared the prevention methods.
Cabotegravir injections and daily Truvada are both highly effective, but some people may find it easier to use the long-acting regimen.
The new prevention approach shows promise, but it isn’t heading to the clinic anytime soon.
Monthly islatravir pills are just one of the long-acting options in the HIV prevention pipeline.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
